Tecan Group AG · SIX:TECN
Tecan — H1 2011 Earnings Presentation
24 slides from Tecan's earnings presentation, Aug 18, 2011
Slide 1: Half Year Results 2011
Zürich, August 18th 2011 Half Year Results 2011 Analyst & Media Conference Call
Slide 2: Speakers
Speakers Thomas Bachmann, CEO Dr. Rudolf Eugster, CFO
Slide 3: Agenda
Tecan Half Year Results 2011 / August 18th 2011 / p3 Agenda • Introduction & Summary Thomas Bachmann • Financial Results Dr. Rudolf Eugster • Strategy & Outlook Thomas Bachmann • Questions & Answers
Slide 4: H1 2011: Substantial Sales Growth in Local Currencies
Tecan Half Year Results 2011 / August 18th 2011 / p4 H1 2011: Substantial Sales Growth in Local Currencies Sales 200 180 • Sales growth of 12.3% in local currencies 160 • Sales increased by 2.2% in CHF 140 Rest of World 120 Asia • Europe: 11.5% above prior year in local currencies 100 Europe • North
Slide 5: H1 2011 – Strong Business Performance
Tecan Half Year Results 2011 / August 18th 2011 / p5 H1 2011 – Strong Business Performance • Sales growth was broad-based, encompassing both business segments • Life Sciences Business (end-customer business): up 18.1% in LC • Partnering Business (OEM business): 5.7% above prior-year level in LC • Go
Slide 6: Agenda
Tecan Half Year Results 2011 / August 18th 2011 / p6 Agenda • Introduction & Summary Thomas Bachmann • Financial Results Dr. Rudolf Eugster • Strategy & Outlook Thomas Bachmann • Questions & Answers
Slide 7: H1 2011 Sales Performance
Tecan Half Year Results 2011 / August 18th 2011 / p7 H1 2011 Sales Performance Sales (as reported) 200 180 178.0 181.9 • Sales H1 2011 vs. H1 2010 160 140 • +2.2% in Swiss Francs 120 100 80 • +12.3% in local currencies 60 CHF (mio) 40 20 0 • Order Entry H1 2011 vs. H1 2010 2010 2011 • +1.3% in Swiss
Slide 8: H1 2011 Gross Profit
Tecan Half Year Results 2011 / August 18th 2011 / p8 H1 2011 Gross Profit Gross Profit (% = as a % of sales) 100 90 88.8 90.8 • Gross profit increased to CHF 90.8m 80 70 • CHF 2.0m or 2.2% above H1 2010 60 50 49.9% • Gross profit margin was stable at 49.9% 49.9% 40 CHF (mio) 30 20 10 • -1.0% exchang
Slide 9: H1 2011 Cost Structure
Tecan Half Year Results 2011 / August 18th 2011 / p9 H1 2011 Cost Structure Operating Expenses (% = as a % of sales) 80 70.0m • Costs increased by CHF 4.0m (+6.0%) 66.0m (38.5%) (37.1%) • Selling & Marketing decreased by 5.3% 18.5 60 17.9 (10.2%) G&A • Positive FX effect from cost in Market Units (1
Slide 10: H1 2011 EBIT
Tecan Half Year Results 2011 / August 18th 2011 / p10 H1 2011 EBIT EBIT (% = as a % of sales) 25 23.1 • EBIT reached CHF 20.8m 20.8 20 • CHF 2.3m below H1 2010: • Negative exchange rate effect of CHF 6.6m 15 • Positive net effect of CHF 4.3m due to – increased volume (+) 10 11.5% 13.0% – product mix
Slide 11: H1 2011 Net Profit
Tecan Half Year Results 2011 / August 18th 2011 / p11 H1 2011 Net Profit % = Net Profit as a % of sales • Net profit increased by 49.4% to 25 23.3 CHF 23.3m • Due to better financial result of 20 CHF 6.2m (H1 2010: loss of CHF 4.0m) and a lower tax rate 15.6 15 • Tax rate decreased to 13.6% (H1 2010
Slide 12: H1 2011 Basic Earnings per Share
Tecan Half Year Results 2011 / August 18th 2011 / p12 H1 2011 Basic Earnings per Share 2.5 2.17 2 • Earnings per share increased by 44.7% to CHF 2.17 1.50 1.5 • Highest value for first half year in Tecan’s history 1 • Increased along with increased Net Profit CHF / share 0.5 0 2010 2011 • Average nu
Slide 13: H1 2011 Cash Flow
Tecan Half Year Results 2011 / August 18th 2011 / p13 H1 2011 Cash Flow 160000 +18.0m 140000 137.1m 138.5m -4.6m Cash at end 120000 100000 from from -12.0m3 80000 Operations Investments2 from of H1 2011 60000 40000 Cash at Financing 20000 0 January 11 • Solid cash flow from operations of CHF 18.0m (
Slide 14: H1 2011 Segment Sales
Tecan Half Year Results 2011 / August 18th 2011 / p14 H1 2011 Segment Sales Sales (in CHF millions) 120.0 • Life Sciences Business: • Sales 3.1% up in CHF and 18.1% in local 99.2 102.3 100.0 currencies 78.8 79.5 80.0 • Considerable increase in demand for liquid 2010 handling platforms in Biopharma a
Slide 15: H1 2011 Segment Profitability
Tecan Half Year Results 2011 / August 18th 2011 / p15 H1 2011 Segment Profitability EBIT (in CHF millions) 25.0 23.3 23.4 20.0 • Life Sciences Business: • EBIT and EBIT margin below prior year due to: 15.0 • Negative FX effect of 4.4 percentage points; 2010 2011 EBIT margin at constant currencies of
Slide 16: H1 2011 Regional Sales Development
Tecan Half Year Results 2011 / August 18th 2011 / p16 H1 2011 Regional Sales Development YoY % YoY % +0.4% in LC YoY % • Europe: significant negative exchange - 9.7% in CHF rate impact; substantial growth of end- - 6.2% in LC +20.6% in LC user sales of liquid handling platforms; - 15.2% in CHF Other
Slide 17: H1 2011 Key Figures
Tecan Half Year Results 2011 / August 18th 2011 / p17 H1 2011 Key Figures CHF m 2010 2011 Δ 10/11 Sales 178.0 181.9 2.2% Gross Profit 88.8 90.8 2.2% in % of sales 49.9% 49.9% R&D 18.3 23.2 27.3% in % of sales 10.3% 12.8% OPEX 66.0 70.0 6.0% in % of sales 37.1% 38.5% Operating profit / EBIT 23.1 20.8
Slide 18: Agenda
Tecan Half Year Results 2011 / August 18th 2011 / p18 Agenda • Introduction & Summary Thomas Bachmann • Financial Results Dr. Rudolf Eugster • Strategy & Outlook Thomas Bachmann • Questions & Answers
Slide 19: Key Priorities 2011
Tecan Half Year Results 2011 / August 18th 2011 / p19 Key Priorities 2011 As shown on March 10, 2011 Update August 18, 2011 • Important milestones are scheduled • Important milestones reached in all to be achieved during 2011 major R&D programs; more are Drive • Various key programs ongoing in sched
Slide 20: Key Priorities 2011
Tecan Half Year Results 2011 / August 18th 2011 / p20 Key Priorities 2011 As shown on March 10, 2011 Update August 18, 2011 • New Tecan Group organization • New organization established; management and skills to support execution of growth strengthened; transition went Benefit from strategy new Grou
Slide 21: Outlook for Full Year 2011
Tecan Half Year Results 2011 / August 18th 2011 / p21 Outlook for Full Year 2011 Sales FY 2011 Profitability FY 2011 As of March 10, 2011 EBIT Margin of 12-13% Mid-single-digit sales growth in Based on average FX rates of: local currencies 1.30 EUR/CHF and 1.00 USD/CHF Updated guidance as of August
Slide 22: Agenda
Tecan Half Year Results 2011 / August 18th 2011 / p22 Agenda • Introduction & Summary Thomas Bachmann • Financial Results Dr. Rudolf Eugster • Strategy & Outlook Thomas Bachmann • Questions & Answers
Slide 23: Next Events / Contact
Tecan Half Year Results 2011 / August 18th 2011 / p23 Next Events 2011: December 1: Analyst & Investor Day 2012: March 8: Full Year 2011 financial results April 18: Annual Shareholder Meeting Contact Martin Braendle Head of Corporate Communications & Investor Relations Phone: +41 (0) 44 922 84 30 in
Slide 24: Safe Harbor Statement
Safe Harbor Statement All statements in this presentation not referring to historical facts are predictions of the future and constitute no guarantee whatsoever of future performances. They are subject to risks and uncertainties including, but not limited to, future global economic conditions, excha